Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A recombinant fusion protein drug consisting of interferon alpha (IFN-α) linked to human albumin.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word albinterferon.
Examples
-
Novartis said the Swiss company and partner Human Genome Sciences Inc. will stop development of chronic hepatitis C compound albinterferon alfa-2b.
Novartis Cites Discontinued Drugs for Charge Goran Mijuk 2010
-
The decision comes after Novartis said in October it will stop the development of chronic hepatitis C compound albinterferon alfa-2b and also end research of Mycograb, an antifungal agent.
Novartis Ends Work on Drug Goran Mijuk 2010
-
Novartis has withdrawn its MAA for Joulferon® (albinterferon alfa-2b) for the treatment of chronic hepatitis C.
GEN News Highlights 2010
-
In both studies half the injections of albinterferon alfa-2b achieved sustained virologic response comparable to that achieved by peginterferon alfa-2a, they add.
GEN News Highlights 2010
-
Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that Novartis has withdrawn a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for approval to market JOULFERON® (albinterferon alfa-2b, known in the United States as ZALBIN ™) for the treatment of chronic hepatitis C.
THE MEDICAL NEWS Editors 2010
-
Novartis will be responsible for commercialization of albinterferon alfa-2b in the rest of the world under the brand name Joulferon, and will pay HGS a royalty on those sales.
SeekingAlpha.com: Home Page George Chadwick 2010
-
Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that Novartis has withdrawn a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for approval to market JOULFERON® (albinterferon alfa-2b, known in the United States as ZALBIN ™) for the treatment of chronic hepatitis C.
THE MEDICAL NEWS Editors 2010
-
In both studies half the injections of albinterferon alfa-2b achieved sustained virologic response comparable to that achieved by peginterferon alfa-2a, they add.
GEN News Highlights 2010
-
Novartis has withdrawn its MAA for Joulferon® (albinterferon alfa-2b) for the treatment of chronic hepatitis C.
GEN News Highlights 2010
-
Novartis has withdrawn its MAA for Joulferon® (albinterferon alfa-2b) for the treatment of chronic hepatitis C.
GEN News Highlights 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.